Publications

The Lancet. Oncology

The OligoPanc project: an interdisciplinary expert consensus statement on oligometastatic pancreatic cancer.

01-03-2026

European journal of radiology

Corrigendum to "RECIST progression: Patterns among target, non-target, non-measurable and new lesions progression" [Eur. J. Radiol. 186 (2025) 112038].

01-03-2026

Annals of oncology : official journal of the European Society for Medical Oncology

Repertoire and clinical hierarchy of AR locus alterations in castration-resistant prostate cancer.

01-03-2026

Annals of surgical oncology

International Survey on Evidence for Index Lymph Node Surgery After Neoadjuvant Systemic Therapy for Stage III Melanoma.

01-03-2026

Journal of biomedical optics

Perspective on the current state of hyperspectral/multispectral imaging for minimally invasive surgery.

01-03-2026

Clinical breast cancer

Long-Term Health Issues of Adolescent and Young Adult Breast Cancer Survivors.

01-03-2026

Annals of surgical oncology

ASO Author Reflections: Reported rationales for the content of prehabilitation programs in the oncology setting.

01-03-2026

European journal of nuclear medicine and molecular imaging

[¹⁸F]FDG-PET/CT's change in total lesion glycolysis can accurately identify early response upon neoadjuvant immunotherapy prior to curative-intent surgery in cutaneous squamous cell carcinoma; MATISSE trial.

01-03-2026

Annals of surgical oncology

ASO Visual Abstract: Prognostic Value of Circulating Tumor DNA for Recurrence and Survival in Patients Undergoing Local Treatment for Initially Unresectable RAS/RAF Mutated Colorectal Cancer Liver Metastases.

01-03-2026

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Are the CTV-to-PTV margins currently used in online adaptive radiotherapy for prostate cancer too large? The impact of the distribution of microscopic disease on treatment margin requirements.

01-03-2026

Nature cancer

Temporal and spatial composition of the tumor microenvironment predicts response to immune checkpoint inhibition in metastatic TNBC.

01-03-2026

Scientific reports

Effect of curcumin on the gut microbiota of patients with ulcerative colitis, Crohn's disease and healthy participants.

01-03-2026

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Acute adverse events in the DESTINATION 1 trial: A prospective prostate SBRT dose de-escalation feasibility study.

01-03-2026

Technical innovations & patient support in radiation oncology

Direct-to-treatment MRI-guided prostate radiotherapy using a generic patient-agnostic reference plan.

01-03-2026

Nature chemistry

Monovalent pseudo-natural products supercharge degradation of IDO1 by its native E3 KLHDC3.

01-03-2026

ESMO open

Nivolumab plus gemcitabine-cisplatin for unresectable or metastatic urothelial carcinoma: health-related quality-of-life analyses from the phase III CheckMate 901 trial.

01-03-2026

NAR genomics and bioinformatics

DEprot: a comprehensive R-package for the analysis of label-free quantitation mass spectrometry data.

01-03-2026

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Prevalence of concurrent severe self-reported late symptoms and functional limitations in cancer survivors: a cross-sectional study of sociodemographic, clinical, and lifestyle associations.

28-02-2026

Frontiers in toxicology

Evaluating chemotherapy-driven placental alterations and their impact on fetal development.

27-02-2026

Breast cancer research : BCR

Pathway activity profiling can predict neoadjuvant endocrine therapy response in HR+ HER2- postmenopausal early stage breast cancer.

25-02-2026

European journal of cancer (Oxford, England : 1990)

Assessing quality of life in individuals with hereditary cancer risk: Results from phases 1-3a of the EORTC QLQ-HCR30 questionnaire.

25-02-2026

Blood advances

Fludarabine dosing in the youngest children: safety first.

24-02-2026

Communications biology

PRC2 loss impairs small cell lung cancer tumorigenesis and enhances sensitivity to G9a/GLP inhibition.

21-02-2026

iScience

Compartment-specific tumor-infiltrating immune cells and prognosis in breast cancer.

20-02-2026

Health and quality of life outcomes

Incorporating patients' input in the development and validation of patient-reported outcome measures in oncology: a comprehensive scoping review.

18-02-2026

Cell reports. Medicine

Liver metastases dampen IL18-driven γδ T cell activity and immunotherapy responsiveness in colorectal cancer.

17-02-2026

Cellular oncology (Dordrecht, Netherlands)

Disconnect between in vitro and in vivo efficacy of the MPS1 inhibitor NTRC 0066-0 against glioblastoma.

16-02-2026

International journal of cancer

Experiences of metastatic prostate cancer patients with a mainstream genetic testing pathway.

15-02-2026

International journal of cancer

Cause-specific mortality after a diagnosis of ductal carcinoma in situ: Associations with screening and socio-economic status.

15-02-2026

Therapeutic drug monitoring

Impact of Abiraterone Therapeutic Drug Monitoring on Cortisol as a Surrogate Biomarker of CYP17 Inhibition in Metastatic Prostate Cancer Treatment.

13-02-2026

Journal of experimental & clinical cancer research : CR

Tertiary lymphoid structures in the era of cancer therapy.

11-02-2026

RSC chemical biology

Identification of mono-ADP-ribose readers using well-defined photoaffinity-based probes.

11-02-2026

PloS one

Patients' and relatives' perspectives on the quality of end-of-Life care in advanced cancer: From the final months to bereavement.

09-02-2026

Cancer discovery

Mind the GARP: How Glucocorticoids Unleash T Cells against Melanoma.

06-02-2026

Science (New York, N.Y.)

Synergy between regulatory elements can render cohesin dispensable for distal enhancer function.

05-02-2026

Nature communications

NEO-STIM advances personalized neoantigen-specific adoptive T cell therapy.

05-02-2026

The oncologist

Age and sex as risk factors for health-related quality of life outcomes in patients with glioma: a CODAGLIO 2.0 analysis.

05-02-2026

Breast (Edinburgh, Scotland)

Trends in local, regional and contralateral breast tumor recurrence within five years after diagnosis in the Netherlands: a population-based study including 121347 patients.

01-02-2026

European urology oncology

Novel Molecular Biomarkers to Guide Treatment Decision-making in Metastatic Urothelial Cancer-A Patient Cohort Analysis.

01-02-2026

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

ESMO-ESTRO consensus statements on the safety of combining radiotherapy with CDK4/6, HER2, PARP, or mTOR inhibitors.

01-02-2026

Oncogene

MDC1 counteracts replication fork reversal and mediates chemosensitivity in BRCA1/2-deficient tumors.

01-02-2026

Clinical pharmacokinetics

Population Pharmacokinetics of Total and Protein-Unbound Prednisolone in Children with Immune-Mediated and Systemic Inflammatory Diseases.

01-02-2026

Journal of cancer survivorship : research and practice

Eight-year follow-up of patient-reported outcomes in patients with breast cancer participating in exercise studies during chemotherapy.

01-02-2026

Biomedical chromatography : BMC

An Overview of Liquid Chromatography-Mass Spectrometry (LC-MS) Methods for the Quantification of Antibody-Drug Conjugates.

01-02-2026

Breast (Edinburgh, Scotland)

Eligibility for bilateral prophylactic mastectomy: An expert opinion study in the Netherlands.

01-02-2026

The American journal of surgical pathology

Performance Assessment of a Deep Learning-based Algorithm for Ovarian Cancer Histotyping in an Independent Data Set.

01-02-2026

Annals of surgical oncology

Prognostic Value of Circulating Tumor DNA for Recurrence and Survival in Patients Undergoing Local Treatment for Initially Unresectable RAS/RAF Mutated Colorectal Cancer Liver Metastases.

01-02-2026

JAMA otolaryngology-- head & neck surgery

Patient-Reported Outcomes Across Treatment Strategies in Papillary Thyroid Microcarcinoma: A Meta-Analysis.

01-02-2026

JAMA oncology

Enhancing Clinical Cancer Research Through Sharing of Data and Biospecimens.

01-02-2026

Molecular oncology

Developing evidence-based, cost-effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities.

01-02-2026

The OligoPanc project: an interdisciplinary expert consensus statement on oligometastatic pancreatic cancer.

Corrigendum to "RECIST progression: Patterns among target, non-target, non-measurable and new lesions progression" [Eur. J. Radiol. 186 (2025) 112038].

Repertoire and clinical hierarchy of AR locus alterations in castration-resistant prostate cancer.

International Survey on Evidence for Index Lymph Node Surgery After Neoadjuvant Systemic Therapy for Stage III Melanoma.

Perspective on the current state of hyperspectral/multispectral imaging for minimally invasive surgery.

Long-Term Health Issues of Adolescent and Young Adult Breast Cancer Survivors.

ASO Author Reflections: Reported rationales for the content of prehabilitation programs in the oncology setting.

[18F]FDG-PET/CT's change in total lesion glycolysis can accurately identify early response upon neoadjuvant immunotherapy prior to curative-intent surgery in cutaneous squamous cell carcinoma; MATISSE trial.

ASO Visual Abstract: Prognostic Value of Circulating Tumor DNA for Recurrence and Survival in Patients Undergoing Local Treatment for Initially Unresectable RAS/RAF Mutated Colorectal Cancer Liver Metastases.

Are the CTV-to-PTV margins currently used in online adaptive radiotherapy for prostate cancer too large? The impact of the distribution of microscopic disease on treatment margin requirements.

Temporal and spatial composition of the tumor microenvironment predicts response to immune checkpoint inhibition in metastatic TNBC.

Effect of curcumin on the gut microbiota of patients with ulcerative colitis, Crohn's disease and healthy participants.

Acute adverse events in the DESTINATION 1 trial: A prospective prostate SBRT dose de-escalation feasibility study.

Direct-to-treatment MRI-guided prostate radiotherapy using a generic patient-agnostic reference plan.

Monovalent pseudo-natural products supercharge degradation of IDO1 by its native E3 KLHDC3.

Nivolumab plus gemcitabine-cisplatin for unresectable or metastatic urothelial carcinoma: health-related quality-of-life analyses from the phase III CheckMate 901 trial.

DEprot: a comprehensive R-package for the analysis of label-free quantitation mass spectrometry data.

Prevalence of concurrent severe self-reported late symptoms and functional limitations in cancer survivors: a cross-sectional study of sociodemographic, clinical, and lifestyle associations.

Evaluating chemotherapy-driven placental alterations and their impact on fetal development.

Pathway activity profiling can predict neoadjuvant endocrine therapy response in HR+ HER2- postmenopausal early stage breast cancer.

Assessing quality of life in individuals with hereditary cancer risk: Results from phases 1-3a of the EORTC QLQ-HCR30 questionnaire.

Fludarabine dosing in the youngest children: safety first.

PRC2 loss impairs small cell lung cancer tumorigenesis and enhances sensitivity to G9a/GLP inhibition.

Compartment-specific tumor-infiltrating immune cells and prognosis in breast cancer.

Incorporating patients' input in the development and validation of patient-reported outcome measures in oncology: a comprehensive scoping review.

Liver metastases dampen IL18-driven γδ T cell activity and immunotherapy responsiveness in colorectal cancer.

Disconnect between in vitro and in vivo efficacy of the MPS1 inhibitor NTRC 0066-0 against glioblastoma.

Experiences of metastatic prostate cancer patients with a mainstream genetic testing pathway.

Cause-specific mortality after a diagnosis of ductal carcinoma in situ: Associations with screening and socio-economic status.

Impact of Abiraterone Therapeutic Drug Monitoring on Cortisol as a Surrogate Biomarker of CYP17 Inhibition in Metastatic Prostate Cancer Treatment.

Tertiary lymphoid structures in the era of cancer therapy.

Identification of mono-ADP-ribose readers using well-defined photoaffinity-based probes.

Patients' and relatives' perspectives on the quality of end-of-Life care in advanced cancer: From the final months to bereavement.

Mind the GARP: How Glucocorticoids Unleash T Cells against Melanoma.

Synergy between regulatory elements can render cohesin dispensable for distal enhancer function.

NEO-STIM advances personalized neoantigen-specific adoptive T cell therapy.

Age and sex as risk factors for health-related quality of life outcomes in patients with glioma: a CODAGLIO 2.0 analysis.

Trends in local, regional and contralateral breast tumor recurrence within five years after diagnosis in the Netherlands: a population-based study including 121347 patients.

Novel Molecular Biomarkers to Guide Treatment Decision-making in Metastatic Urothelial Cancer-A Patient Cohort Analysis.

ESMO-ESTRO consensus statements on the safety of combining radiotherapy with CDK4/6, HER2, PARP, or mTOR inhibitors.

MDC1 counteracts replication fork reversal and mediates chemosensitivity in BRCA1/2-deficient tumors.

Population Pharmacokinetics of Total and Protein-Unbound Prednisolone in Children with Immune-Mediated and Systemic Inflammatory Diseases.

Eight-year follow-up of patient-reported outcomes in patients with breast cancer participating in exercise studies during chemotherapy.

An Overview of Liquid Chromatography-Mass Spectrometry (LC-MS) Methods for the Quantification of Antibody-Drug Conjugates.

Eligibility for bilateral prophylactic mastectomy: An expert opinion study in the Netherlands.

Performance Assessment of a Deep Learning-based Algorithm for Ovarian Cancer Histotyping in an Independent Data Set.

Prognostic Value of Circulating Tumor DNA for Recurrence and Survival in Patients Undergoing Local Treatment for Initially Unresectable RAS/RAF Mutated Colorectal Cancer Liver Metastases.

Patient-Reported Outcomes Across Treatment Strategies in Papillary Thyroid Microcarcinoma: A Meta-Analysis.

Enhancing Clinical Cancer Research Through Sharing of Data and Biospecimens.

Developing evidence-based, cost-effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities.

This site uses cookies

[¹⁸F]FDG-PET/CT's change in total lesion glycolysis can accurately identify early response upon neoadjuvant immunotherapy prior to curative-intent surgery in cutaneous squamous cell carcinoma; MATISSE trial.